G

Guangdong Hec Technology Holding Co Ltd
SSE:600673

Watchlist Manager
Guangdong Hec Technology Holding Co Ltd
SSE:600673
Watchlist
Price: 33.22 CNY 2.28% Market Closed
Market Cap: ¥100B

P/OCF

75
Current
44%
More Expensive
vs 3-y average of 52

Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.

P/OCF
75
=
Market Cap
¥96B
/
Operating Cash Flow
¥1.3B

Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.

P/OCF
75
=
Market Cap
¥96B
/
Operating Cash Flow
¥1.3B

Valuation Scenarios

Guangdong Hec Technology Holding Co Ltd is trading above its 3-year average

If P/OCF returns to its 3-Year Average (52), the stock would be worth ¥23.03 (31% downside from current price).

Statistics
Positive Scenarios
0/4
Maximum Downside
-76%
Maximum Upside
No Upside Scenarios
Average Downside
58%
Scenario P/OCF Value Implied Price Upside/Downside
Current Multiple 75 ¥33.22
0%
3-Year Average 52 ¥23.03
-31%
5-Year Average 38.7 ¥17.13
-48%
Industry Average 18.3 ¥8.09
-76%
Country Average 18.3 ¥8.08
-76%

Forward P/OCF
Today’s price vs future operating cash flow

Not enough data available to calculate forward P/OCF

Peer Comparison

All Multiples
P/OCF
P/E
All Countries
Close

Market Distribution

Higher than 84% of companies in China
Percentile
84th
Based on 6 232 companies
84th percentile
75
Low
0.2 — 9.8
Typical Range
9.8 — 36.5
High
36.5 —
Distribution Statistics
China
Min 0.2
30th Percentile 9.8
Median 18.3
70th Percentile 36.5
Max 266 666.7

Guangdong Hec Technology Holding Co Ltd
Glance View

Market Cap
100B CNY
Industry
Metals & Mining

Nestled in the vibrant economic landscape of China, Guangdong Hec Technology Holding Co Ltd operates with the intricacies of a well-oiled machine in the health sector. The company, with its focal point in pharmaceuticals, has been a significant player in the development, manufacturing, and sale of a variety of medicinal products. Its portfolio spans across anti-infectives, digestive medications, and cardiovascular treatments, amassing a reputation for innovation and quality. The company’s commitment to research and development is palpable, as it consistently invests in state-of-the-art laboratories and collaborations with leading scientific minds. This approach not only fuels its pipeline of groundbreaking therapies but also ensures a steady stream of products ready for market. The company's revenue engine hums efficiently through a strategic blend of domestic and international market penetration. By leveraging an extensive distribution network, Guangdong Hec Technology ensures its products reach both regional pharmacies and global pharmaceutical markets. Through meticulous marketing strategies and strategic partnerships, the company has adeptly navigated the complex waters of regulatory compliance and competitive pricing landscapes. Its financial fortitude is further bolstered by a judicious mix of pharmaceutical exports and local sales, highlighting its dual focus on global expansion and domestic consolidation. In this dance of science and commerce, Guangdong Hec Technology continues to solidify its stature, harnessing both innovation and keen business acumen to thrive in the ever-evolving pharmaceutical industry.

Intrinsic Value
15.22 CNY
Overvaluation 54%
Intrinsic Value
Price ¥33.22
G
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett